CTAD 2024 | An automated speech tool to screen for cognitive impairment: a study in four European cohorts

Alexandra König, PhD, ki:elements, Saarbrücken, Germany, discusses a study that investigated the effectiveness of an automated speech tool in screening for cognitive impairment in four European cohorts. Features of speech were extracted from a phone call to produce a composite score to distinguish healthy from cognitively impaired individuals. Dr König believes that this technology has the potential to be used in clinical trials for pre-screening and in primary care settings, to aid in early diagnosis and guiding treatment. This interview took place at the 17th Clinical Trials on Alzheimer’s Disease (CTAD) congress in Madrid, Spain.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.